RT Journal Article
SR Electronic
T1 Sequential data assimilation of the stochastic SEIR epidemic model for regional COVID-19 dynamics
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.13.20063768
DO 10.1101/2020.04.13.20063768
A1 Engbert, Ralf
A1 Rabe, Maximilian M.
A1 Kliegl, Reinhold
A1 Reich, Sebastian
YR 2020
UL http://medrxiv.org/content/early/2020/06/30/2020.04.13.20063768.abstract
AB Newly emerging pandemics like COVID-19 call for predictive models to implement precisely tuned responses to limit their deep impact on society. Standard epidemic models provide a theoretically well-founded dynamical description of disease incidence. For COVID-19 with infectiousness peaking before and at symptom onset, the SEIR model explains the hidden build-up of exposed individuals which creates challenges for containment strategies. However, spatial heterogeneity raises questions about the adequacy of modeling epidemic outbreaks on the level of a whole country. Here, we show that by applying sequential data assimilation to the stochastic SEIR epidemic model, we can capture the dynamic behavior of outbreaks on a regional level. Regional modeling, with relatively low numbers of infected and demographic noise, accounts for both spatial heterogeneity and stochasticity. Based on adapted models, short-term predictions can be achieved. Thus, with the help of these sequential data assimilation methods, more realistic epidemic models are within reach.Competing Interest StatementThe authors have declared no competing interest.Funding StatementOur work was supported by a grant from Deutsche Forschungsgemeinschaft, Germany (SFB 1294,project no. 318763901).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are publicly available via Robert Koch Institute (RKI), Berlin, Germany, at https://npgeo-corona-npgeo-de.hub.arcgis.com/, accessed: 2020-04-08; source code (R Language of Statistical Computing) and data used in our study are available via Open Science Framework (OSF). https://osf.io/7dshm/